Intelligent Bio Solutions... (INBS)
2.10
-0.54 (-20.45%)
At close: Feb 20, 2025, 3:59 PM
2.09
-0.48%
After-hours: Feb 20, 2025, 05:54 PM EST
undefined% (undefined)
| Bid | 2.09 |
| Market Cap | 11.09M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0.12 |
| PE Ratio (ttm) | 17.5 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.13 |
| Volume | 587,485 |
| Avg. Volume (20D) | 190,388 |
| Open | 2.36 |
| Previous Close | 2.64 |
| Day's Range | 2.04 - 2.20 |
| 52-Week Range | 1.00 - 5.63 |
| Beta | undefined |
About INBS
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a b...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Dec 23, 2020
Employees 50
Stock Exchange NASDAQ
Ticker Symbol INBS
Website https://gbs.inc
Next Earnings Release
Intelligent Bio Solutions Inc. is scheduled to release its earnings on Feb 25, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 day ago
Intelligent Bio Solutions shares are trading lower...
Unlock content with
Pro Subscription
1 week ago
+19.71%
Intelligent Bio Solutions shares are trading higher. The stock may be moving on continued strength after the company released on Monday a shareholder letter highlighting its growth for 2024 and strategy for 2025.
